Lion Set to Close Two i-Biology Deals Before Q4; Says Courting Acquisition Target | GenomeWeb

NEW YORK, Nov. 7 – Lion Bioscience is ready to close two large i-Biology partnerships in the coming months and has set its sights on a “very promising” potential acquisition target, the company told GenomeWeb.

While Lion would not disclose the names of the companies linked to these partnerships, an analyst said he “suspects” one might be a major California-based pharmaceutical company and the other is likely a top-20 European pharma firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.